AccuRna
Latest round
- Series B
Last raised
- Dec 2019
Total raised
- $4.7M
Investors
- 4
About AccuRna
Founded in 2015 and based in Tokyo, Japan, AccuRna, Inc. is a solution provider in the area of nucleic acid therapeutics. The Company develops the drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug, providing treatment for refractory diseases.
Who invested in AccuRna
4 investors across 3 rounds
See all investors in AccuRna
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AccuRna
Who invested in AccuRna?
AccuRna has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AccuRna raised?
AccuRna has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did AccuRna last raise money?
AccuRna's most recent round on record is a Series B, in Dec 2019.
What does AccuRna do?
Founded in 2015 and based in Tokyo, Japan, AccuRna, Inc.
Where is AccuRna headquartered?
AccuRna is headquartered in Tokyo, Japan.
Which VCs invest in companies like AccuRna?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at AccuRna's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like AccuRna? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.